Gasdermin D and Gasdermin E Are Dispensable for Silica-Mediated IL-1β Secretion from Mouse Macrophages
Description
Silica crystals activate the NLRP3 inflammasome in macrophages, resulting in the caspase-1-dependent secretion of the proinflammatory cytokine IL-1β. Caspase-1-mediated cleavage of gasdermin D (GSDMD) triggers the formation of GSDMD pores, which drive pyroptotic cell death and facilitate the rapid release of IL-1β. However, the role of GSDMD in silica-induced lung injury is unclear. In this study, we show that although silica-induced lung injury is dependent on the inflammasome adaptor ASC and IL-1R1 signaling, GSDMD is dispensable for acute lung injury. Although the early rapid secretion of IL-1β in response to ATP and nigericin was GSDMD dependent, GSDMD was not required for IL-1β release at later time points. Similarly, secretion of IL-1β from macrophages in response to silica and alum proceeded in a GSDMD-independent manner. We further found that gasdermin E did not contribute to macrophage IL-1β secretion in the absence of GSDMD in vitro and was also not necessary for silica-induced acute lung injury in vivo. These findings demonstrate that GSDMD and gasdermin E are dispensable for IL-1β secretion in response to silica in vitro and in silica-induced acute lung injury in vivo.
Files
Figure 2A GSDMD_IL1b_Casp1_Actin Sups Lysates Western blot .pdf
Files
(2.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:3e173c7e09fc32e140b5984c5e15329b
|
31.8 kB | Download |
|
md5:bc8971666613a8c7fdadc3d657517a4d
|
29.2 kB | Download |
|
md5:0ab62f00bf5d012c59c495f7c1785822
|
23.3 kB | Download |
|
md5:55481d9c45771046c1f6e3aed82617a3
|
25.5 kB | Download |
|
md5:2cb74fe885c5c724878fd40463f03bbc
|
11.6 kB | Download |
|
md5:163c954390f0048b0cba0f74c2c99361
|
579.8 kB | Preview Download |
|
md5:8fa79b316120f17f746e30101605734f
|
21.3 kB | Download |
|
md5:36c328a6c7ce26fc586faf9c9e5f0bbc
|
29.8 kB | Download |
|
md5:6f11740b3ecfe04dd74dc76f671709a0
|
21.2 kB | Download |
|
md5:0462baada61a7cef84d4d727878199b7
|
30.9 kB | Download |
|
md5:c6a735e0839f33bfb1796bdf48a15ff6
|
39.9 kB | Download |
|
md5:d379c5313622135bd048bfa956ff01d4
|
125.1 kB | Download |
|
md5:c0da601ac5017f02804fdf1c434d13fa
|
332.2 kB | Download |
|
md5:a691cfbcc5da69c6841943ca2126d852
|
173.6 kB | Download |
|
md5:0935c88e137713afe26935364d792c0a
|
34.9 kB | Download |
|
md5:bc3374bb1702c13bc0f935cacbe058f0
|
150.5 kB | Download |
|
md5:62413097349e4894189d0e279071ad9f
|
25.6 kB | Download |
|
md5:e02eed29fd2d5b0a37e3fbe82dfc71ef
|
23.5 kB | Download |
|
md5:7f526a075638b9232e1f3748ae0f2fc3
|
25.6 kB | Download |
|
md5:f0b4dc5f10cac37992a557cfd641eb6d
|
11.8 kB | Download |
|
md5:429e21268e4fb2c0f02ecb84704fce69
|
29.1 kB | Download |
|
md5:3faafa560b0a3b285c1c16afa8ccd966
|
18.1 kB | Download |
|
md5:4f5387060dcf061d951d531a0f8f1d07
|
21.6 kB | Download |
|
md5:acbb915e8de2e1047347d4ed6cbea135
|
21.2 kB | Download |
|
md5:e6e2b0624d28dbb9170e1a55357e1c83
|
135.5 kB | Download |
|
md5:20a6fe4fd2be5644f9b3aa2a4b989849
|
18.2 kB | Download |
|
md5:ac8d164a88a30ec3dd6e267a22f3af81
|
20.7 kB | Download |
|
md5:7842080b6349579032f2aa10015018e5
|
21.1 kB | Download |
Additional details
Funding
- National Institutes of Health
- R01 AI175101
- National Institutes of Health
- R01 AI177233